This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Quantification and mitigation of system background fluorescence in fiber-optic-based imaging systems.
Biomedical optics express · 2026
Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21): 15-Year Evaluation of an Innovative Research Training Program.
International journal of radiation oncology, biology, physics · 2021
Latest funding
- $120,000
Repurposing the antihypertensive drug telmisartan as a novel immunomodulatory adjuvant to enhance breast cancer immunotherapy
CIHR · 2025 · Supervisor
- $140,000
Stress-induced intracellular amyloid aggregation as a novel mechanism of therapeutic resistance.
CIHR · 2025 · Supervisor
- $994,500
Targeting adaptive autophagy to enhance treatment response in pancreatic cancer
CIHR · 2024 · Co-investigator
2 publications.
Quantification and mitigation of system background fluorescence in fiber-optic-based imaging systems.
Brace E, Malone J, Tanskanen A, Paulus L, Bennewith K, MacAulay C, Lane P
Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21): 15-Year Evaluation of an Innovative Research Training Program.
Patel PS, Vyravanathan S, Milne E, Bezjak A, Wouters BG, Bennewith K, Seuntjens J, Liu ZA, Harding SM, Liu FF, Koritzinsky M, Koch CA
Repurposing the antihypertensive drug telmisartan as a novel immunomodulatory adjuvant to enhance breast cancer immunotherapy
Principal investigators: Clark, Meredith
Keywords: Anti-Hypertensive Drugs; Drug Repurposing; Immunotherapy Adjuvants; Lymphocyte Activation; Macrophages; T Cells; Telmisartan; Tumour Immunology; Tumour Microenvironment
Stress-induced intracellular amyloid aggregation as a novel mechanism of therapeutic resistance.
Principal investigators: Lacroix, Emma C
Keywords: Amyloid Aggregation; Chemotherapy; Combination Therapy; Dormancy; Proliferative Arrest; Radiation Therapy; Tumour Hypoxia
Targeting adaptive autophagy to enhance treatment response in pancreatic cancer
Principal investigators: Gorski, Sharon M
Keywords: Atg4; Autophagy; Biomarker; Cell Lines; Hydroxychloroquine; Mouse Model; Organoids; Pancreatic Cancer; Proof-Of-Principle; Treatment Resistance
Targeting adaptive autophagy to enhance treatment response in pancreatic cancer
Principal investigators: Gorski, Sharon M
Keywords: Atg4; Autophagy; Biomarker; Cell Lines; Hydroxychloroquine; Mouse Model; Organoids; Pancreatic Cancer; Proof-Of-Principle; Treatment Resistance
Ex vivo exposure to hypoxia and exogenous pyruvate improves CD8 T cell anti-tumour function and tumour clearance in vivo
Principal investigators: Hall, Michael G
Keywords: Cd8 T Cells; Elisa; Flow Cytometry; Hypoxia; Immunotherapy; Mass Spectrometry; Metabolism; Tumour Immunology; Tumour Microenvironment; Western Blots
Glucose restriction-mediated changes to mitochondria as a driver of anti-tumour CD8+ T cell function.
Principal investigators: Klein Geltink, Ramon
Keywords: Adoptive Cellular Therapy; Cancer Immunology; Immunometabolism
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
Principal investigators: Bennewith, Kevin L
Keywords: Angiotensin Ii Receptor Blockers; Cancer-Associated Fibroblasts; Flow Cytometry; Hypoxia Markers; Immunofluorescence Microscopy; Renin-Angiotensin System; Solid Tumour Microenvironment; Telmisartan; Tumour Hypoxia; Tumour Perfusion
Simultaneously targeting cancer cells and tumor stroma to improve detection sensitivity and therapeutic efficacy of radiopharmaceuticals
Principal investigators: Lin, Kuo-Shyan
Keywords: Cancer Imaging; Cancer-Associated Fibroblast; Fibroblast-Activation Protein; Gastrin-Releasing Peptide Receptor; Positron Emission Tomography; Prostate-Specific Membrane Antigen; Radiopharmaceuticals; Targeted Radioligand Therapy; Tumor Stroma
Hypoxia promotes treatment-resistance and lineage transformation of EGFR-driven non-small cell lung cancer
Principal investigators: Shi, Rocky
Keywords: Cancer Physiology; Cell Signaling; Drug Resistance; Hypoxia; Lineage Transformation; Lung Cancer; Mouse Models Of Cancer; Tumour Microenvironment
The role of B-1 B cells and natural antibodies in the lung tumor microenvironment
Principal investigators: Cederberg, Rachel
Keywords: Antibodies; B Cells; Cancer Immunology; Immunotherapy; Lung Cancer
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Electrical and Computer Engineering
- Radiation Oncology
- Medical Physics
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.